Hong Kong Integrated Oncology Centre (HKIOC)

Broker's Calls

Ang Peng Tiam's suspension to remain key near-term overhang on TalkMed: CIMB

SINGAPORE (Jan 8): CIMB is maintaining its “hold” call on TalkMed Group with a lower target price of 68 cents from 92 cents previously, after cutting FY17-19F earnings per share (EPS) estimates by 18-21% to factor anticipated earnings losses from the
×